Physician

Alan Keith Miller, M.D.

According to 2025 Medicare claims, Alan Miller, M.D. (NPI: 1649200023) practices urology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Manatee, FL. This provider's primary affiliated billing organization is UROLOGY PARTNERS OF MANATEE, LLC (NPI: 1073327813; TIN: 332768621) and primary practice location at 34205-8628.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 483 traditional Medicare patients, billed 6,561 HCPCS/CPT codes, and received $184,588 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,300 prescription claims across 500 beneficiaries totaling $988,125 in drug costs, led by Xtandi (Enzalutamide). DME data shows 133 claims. Open Payments data shows 45 records totaling $29,327. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $356,495 to $184,588. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $165,317 to $988,125. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $554 and ending at $919.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	758	17,724	$356,495
2016	806	19,601	$318,682
2017	1,221	38,117	$326,779
2018	1,163	16,555	$357,227
2019	980	14,224	$297,745
2020	732	18,748	$267,270
2021	608	18,032	$329,545
2022	549	10,041	$266,643
2023	510	11,770	$209,435
2024	483	6,561	$184,588

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	479	1,862	$165,317
2016	452	1,862	$235,872
2017	468	1,938	$149,074
2018	535	2,033	$265,303
2019	459	1,898	$652,320
2020	407	1,712	$803,225
2021	442	1,873	$1,106,095
2022	479	2,007	$1,178,492
2023	486	2,114	$1,308,316
2024	500	2,300	$988,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	116	$36,928
2016	12	114	$46,708
2017	N/R	141	$58,399
2018	24	138	$61,139
2019	33	190	$87,444
2020	23	147	$63,920
2021	24	142	$61,461
2022	15	157	$60,867
2023	14	145	$50,204
2024	14	133	$56,423

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	127	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	260	408	$86
52000	Diagnostic exam of bladder and urethra using an endoscope	66	81	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	224	272	$62
81003	Automated urinalysis test	266	440	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	23	690	$311,001
Orgovyx	Relugolix	91	2,728	$231,459
Erleada	Apalutamide	13	390	$196,078
Myrbetriq	Mirabegron	197	8,054	$120,217
Gemtesa	Vibegron	62	3,370	$53,800

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	43	$36,396
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	14	76	$19,710
A4332	Lubricant, individual sterile packet, each	N	N/R	14	$318

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$417	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	26	$28,910	Sumitomo Pharma America, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Keith Miller, M.D.?

Tedicare shows public-source Medicare data for Alan Keith Miller, M.D. (NPI 1649200023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Keith Miller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Keith Miller, M.D.?

Alan Keith Miller, M.D. is linked to UROLOGY PARTNERS OF MANATEE, LLC (billing NPI 1073327813) in the available physician profile data.

Does Alan Keith Miller, M.D. have Open Payments data?

Alan Keith Miller, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.